Causal network models of SARS-CoV-2 expression and aging to identify candidates for drug repurposing.
Ontology highlight
ABSTRACT: Given the severity of the SARS-CoV-2 pandemic, a major challenge is to rapidly repurpose existing approved drugs for clinical interventions. While a number of data-driven and experimental approaches have been suggested in the context of drug repurposing, a platform that systematically integrates available transcriptomic, proteomic and structural data is missing. More importantly, given that SARS-CoV-2 pathogenicity is highly age-dependent, it is critical to integrate aging signatures into drug discovery platforms. We here take advantage of large-scale transcriptional drug screens combined with RNA-seq data of the lung epithelium with SARS-CoV-2 infection as well as the aging lung. To identify robust druggable protein targets, we propose a principled causal framework that makes use of multi
SUBMITTER: Belyaeva A
PROVIDER: S-EPMC7884845 | biostudies-literature | 2021 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA